AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi: We have to inform you that the Board of Directors of our company in their meeting held on October 29, 2011 at 2:00 P.M. at 197-A, The Mall, Rawalpindi has not recommended interim cash dividend/bonus shares and/or right shares.
Company’s individual Profit and Loss Account (un-audited) for the first quarter ended September 30, 2011 with comparison of corresponding quarter of the last year is enclosed.
The Share Transfer Books of the Company will not be closed.
Condensed Interim Profit and Loss Account (Un-Audited) For The Three months Ended September 30, 2011
|
Quarter Ended |
Quarter Ended |
||
|
September 30, 2011 |
September 30, 2010 |
||
| Note |
(Rupees) |
(Rupees) |
|
| Sales- net | 394,650,964 | 271,484,333 | |
| Cost of sales | 11 | (181,064,982) | (116,127,786) |
| ———– | ———– | ||
| Gross profit | 213,585,982 | 155,356,547 | |
| Other operating income | 15,208,282 | 17,488,481 | |
| Administrative expenses | (34,917,152) | (23,465,518) | |
| Selling and distribution cost | (86,947,026) | (57,548,137) | |
| Finance cost | (2,365,545) | (3,009,773) | |
| Other charges | (8,439,587) | (7,780,504) | |
| Share in profit of Farmacia – 98% owned partnership firm | 2,143,837 | 1,788,198 | |
| ———– | ———– | ||
| Profit before taxation | 98,268,792 | 82,829,294 | |
| Provision for taxation | (1,990,091) | (138,026) | |
| ———– | ———– | ||
| Profit after taxation | 96,278,700 | 82,691,269 | |
| ———– | ———– | ||
| Earnings per share – basic and diluted | 3.85 | 3.31 |
For more information, contact:
Ferozsons Laboratories Limited
5-KM Sunder Raiwind Road
Raiwind Lahore- Pakistan
Office Ph: +92-42-32104001-3
Fax: +92-42-32104004
Email: info@ferozsons-labs.com